Market Size of Global Orthopedic Biomaterials Industry
Study Period | 2019 - 2029 |
Base Year For Estimation | 2023 |
CAGR | 7.50 % |
Fastest Growing Market | Asia Pacific |
Largest Market | North America |
Market Concentration | Medium |
Major Players*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Orthopedic Biomaterials Market Analysis
The Orthopedic Biomaterials Market is expected to register a CAGR of 7.5% during the forecast period.
Due to nationwide lockdowns during the pandemic, private and public transportation was restricted, resulting in fewer road accidents and injuries. As a result, the focus of the healthcare facilities switched from surgical procedures to COVID-19 patients, which had a short-term impact on the market in the initial pandemic phase, particularly in specialized hospitals. In addition, orthopedic centers and hospitals worldwide were handling only emergency conditions as they were operating with limited resources, while other hospitals were transformed into containment facilities and treatment units for COVID-19 patients. The inevitable pausing of all elective surgeries had limited hands-on practice and exposure to several procedures. Thus, such factors greatly impacted the demand for orthopedic biomaterials during the COVID-19 pandemic globally. However, the post-COVID-19 situation will likely grow as pending procedures increase in the surgical volume.
Moreover, the rising number of sports injuries, an increasing number of trauma cases from accidents, and growing orthopedic surgeries like joint reconstruction and joint arthroplasty are also creating a massive demand for orthopedic biomaterials, thus driving the growth of the orthopedic biomaterial market.
The incidence of sports injuries has increased over the last few years, primarily due to the growing participation in sports as well as active participation in fitness activities. For instance, an article published in June 2021 by Frontiers in Sports and Active Living reported that the 1-year prevalence of a severe sports injury episode was 31%. The most common injury locations for these injuries were the knee (25%), ankle (20%), and hip/groin (15%). Also, the point prevalence of an ongoing injury episode was 19%. The most common locations were the knee (24%), ankle (24%), and foot (24%). Thus, high sports-related injury leads to increasing demand for orthopedic biomaterials, fueling the studied market's growth.
The rising geriatric population, growing incidences of musculoskeletal injuries, and rising numbers of patients opting for knee replacement, construction, and other joint-related orthopedic procedures are expected to drive market growth. According to the United Nations Department of Economic and Social Affairs, World Population Prospects 2022, the share of the global population aged 65 years or above is projected to rise from 10% in 2022 to 16% in 2050. By 2050, the number of persons aged 65 years or over worldwide is projected to be more than twice the number of children under age five and about the same as that of children under age 12. As the growing geriatric population worldwide is more susceptible to joint problems and surgeries, the adoption of orthopedic biomaterials will likely increase over the coming years. Additionally, according to the World Health Organization's update of July 2022, approximately 1.71 billion people have musculoskeletal conditions worldwide. Such a high burden of musculoskeletal conditions results in increased musculoskeletal injuries, which drives the growth of the market for orthopedic biomaterials.
Furthermore, the advancements in the field are also propelling the market's growth. For instance, in October 2021, Osfirm launched a novel implantable Whitlockite Biomaterial. Whitlockite is a form of magnesium tricalcium phosphate that has shown superior bioactive regenerative and reconstructive properties and excellent biocompatibility, making it an ideal biomaterial for implant use on sites of fracture or bone defects.
Thus, the factors above are expected to boost the market's growth throughout the analysis period. However, the lack of reimbursement policies associated with the procedures may hamper the market's growth to a certain extent.
Orthopedic Biomaterials Industry Segmentation
As per the scope, orthopedic biomaterial comprises ceramics, calcium phosphate cement, metals, and polymers, widely used in joint replacement, spine implants, Orth biologics, bioresorbable tissue fixation, and many more. The Orthopedic Biomaterials Market is Segmented By Material Type (Polymers, Ceramics & Bioactive Glasses, Calcium Phosphate Cement, Metal, and Others), By Application (Orthobiologics, Joint Replacement/Reconstruction, Viscosupplementation, Orthopedic Implants, Others), and Geography. (North America, Europe, Asia-Pacific, Middle East, Africa, and South America). The report also covers the estimated market sizes and trends for 17 countries across major global regions. The report offers the value (USD million) for the above segments.
By Material Type | |
Polymers | |
Ceramics & Bioactive Glasses | |
Calcium Phosphate Cements | |
Metal | |
Others |
By Application | |
Orthobiologics | |
Joint Replacement/Reconstruction | |
Viscosupplementation | |
Orthopedic Implants | |
Others |
Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Global Orthopedic Biomaterials Market Size Summary
The orthopedic biomaterials market is poised for significant growth, driven by a combination of factors including the rising incidence of sports injuries, an increasing number of trauma cases, and the growing demand for orthopedic surgeries such as joint reconstruction and arthroplasty. The market experienced a temporary setback during the COVID-19 pandemic due to the postponement of elective surgeries and the redirection of healthcare resources towards managing COVID-19 patients. However, as healthcare systems recover and surgical volumes increase, the demand for orthopedic biomaterials is expected to rise. The market is further bolstered by the aging global population, which is more susceptible to joint problems, and the high prevalence of musculoskeletal conditions, necessitating the use of advanced biomaterials in orthopedic procedures.
Technological advancements and product innovations are also contributing to the market's expansion. The introduction of novel biomaterials, such as Osfirm's Whitlockite Biomaterial and Orthofix Medical's Opus BA, highlights the ongoing development in the field, offering superior properties for bone regeneration and repair. The ceramics and bioactive glasses segment is anticipated to witness robust growth, driven by the increasing adoption of spine surgeries and interbody fusion procedures. North America is expected to maintain a significant market share due to its large geriatric population, high adoption of advanced orthopedic products, and the presence of major pharmaceutical companies. The market's competitive landscape is characterized by the presence of key players like Koninklijke DSM N.V., Zimmer Biomet, and Stryker, who are actively involved in product development and innovation, further propelling market growth.
Global Orthopedic Biomaterials Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.2.1 Rising Prevalence of Geriatric Population
-
1.2.2 Growing Incidences of Musculoskeletal Injuries
-
-
1.3 Market Restraints
-
1.3.1 Reimbursement Policies
-
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Threat of New Entrants
-
1.4.2 Bargaining Power of Buyers/Consumers
-
1.4.3 Bargaining Power of Suppliers
-
1.4.4 Threat of Substitute Products
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION (Market Size by Value-USD million)
-
2.1 By Material Type
-
2.1.1 Polymers
-
2.1.2 Ceramics & Bioactive Glasses
-
2.1.3 Calcium Phosphate Cements
-
2.1.4 Metal
-
2.1.5 Others
-
-
2.2 By Application
-
2.2.1 Orthobiologics
-
2.2.2 Joint Replacement/Reconstruction
-
2.2.3 Viscosupplementation
-
2.2.4 Orthopedic Implants
-
2.2.5 Others
-
-
2.3 Geography
-
2.3.1 North America
-
2.3.1.1 United States
-
2.3.1.2 Canada
-
2.3.1.3 Mexico
-
-
2.3.2 Europe
-
2.3.2.1 Germany
-
2.3.2.2 United Kingdom
-
2.3.2.3 France
-
2.3.2.4 Italy
-
2.3.2.5 Spain
-
2.3.2.6 Rest of Europe
-
-
2.3.3 Asia-Pacific
-
2.3.3.1 China
-
2.3.3.2 Japan
-
2.3.3.3 India
-
2.3.3.4 Australia
-
2.3.3.5 South Korea
-
2.3.3.6 Rest of Asia-Pacific
-
-
2.3.4 Middle East and Africa
-
2.3.4.1 GCC
-
2.3.4.2 South Africa
-
2.3.4.3 Rest of Middle East and Africa
-
-
2.3.5 South America
-
2.3.5.1 Brazil
-
2.3.5.2 Argentina
-
2.3.5.3 Rest of South America
-
-
-
Global Orthopedic Biomaterials Market Size FAQs
What is the current Global Orthopedic Biomaterials Market size?
The Global Orthopedic Biomaterials Market is projected to register a CAGR of 7.5% during the forecast period (2024-2029)
Who are the key players in Global Orthopedic Biomaterials Market?
Koninklijke DSM N.V, Zimmer Biomet, Stryker, Invibio Ltd and Evonik Industries are the major companies operating in the Global Orthopedic Biomaterials Market.